|
V.V. Salukhov, E.A. Kovalevskaya
Amiodarone-induced thyrotoxicosis: a modern view of the problem
|
№3 / 2023
|
|
A.I. Tarzimanova
Modern principles of antiarrhythmic therapy of atrial fibrillation
|
№1-2 / 2023
|
|
M.V. Leonova
Clinically significant drug interactions with warfarin: bleeding risk
|
№13 / 2022
|
|
A.I. Tarzimanova, E.E. Bykova
Antiarrhythmic therapy for atrial fibrillation in patients with the novel SARS-CoV-2 coronavirus infection: how to make the right choice?
|
№13 / 2021
|
|
A.V. Tarasov (1), A.V. Redka (2, 3), E.Z. Shilkina (2, 3)
Factors determining the efficiency and rate of sinus rhythm recovery in pharmacological cardioversion using injectable propafenone and amiodarone
|
№3 / 2021
|
|
E.V. Biryukova (1), N.M. Platonova (2)
AMIODARONE THERAPY AND THYROID FUNCTION
|
№16 / 2017
|
|
T. V. Pavlova, E.Yu.Bulanova, D. V. Duplyakov
Amiodarone And Thyroid Dysfunction
|
№5 / 2013
|
|
V.A. Sulimov, D.A. Napalkov
Role Of Sotalol In The Treatment Of Heart Rhythm Disturbances: Modern Approaches
|
№6 / 2009
|
Русский
